日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies

新型PI3Kδ抑制剂roginolisib与venetoclax在血液系统恶性肿瘤中具有协同作用

Sasi, Binu Kandathilparambil; Tarantelli, Chiara; Martindale, Stephen; Civanelli, Elisa; Cannas, Eleonora; Sartori, Giulio; Arribas, Alberto J; Fernandes, Stacey M; Shupe, Samantha J; Machado, John-Hanson; Tyekucheva, Svitlana; Ren, Yue; Lahn, Michael; Van der Veen, Lars; Di Conza, Giusy; Bertoni, Francesco; Brown, Jennifer R

KAT/3BP: A Metabolism-Targeting Agent with Single and Combination Activity in Aggressive B-Cell Lymphomas.

KAT/3BP:一种针对代谢的靶向药物,对侵袭性 B 细胞淋巴瘤具有单药和联合治疗活性

Tarantelli Chiara, Spriano Filippo, Civanelli Elisa, Aresu Luca, Risi Giorgia, Cannas Eleonora, Kayali Omar, Cascione Luciano, Arribas Alberto J, Stathis Anastasios, Ko Young H, Bertoni Francesco

Screening the Irish Marine Biorepository Identifies a New Bryostatin Analog as Potent Inhibitor of Activated B-Cells Diffuse Large B-Cell Lymphoma

对爱尔兰海洋生物样本库的筛选发现了一种新的布里奥司他汀类似物,该类似物是活化B细胞弥漫性大B细胞淋巴瘤的有效抑制剂。

Jennings, Laurence K; Spriano, Filippo; Reddy, Maggie M; Cascione, Luciano; Civanelli, Elisa; Rinaldi, Andrea; Bertoni, Francesco; Thomas, Olivier P

IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance

IOA-244 是一种非 ATP 竞争性、高选择性、耐受性好的 PI3K Delta 抑制剂,可靶向实体肿瘤并打破免疫耐受性

Zoë Johnson #, Chiara Tarantelli #, Elisa Civanelli, Luciano Cascione, Filippo Spriano, Amy Fraser, Pritom Shah, Tyzoon Nomanbhoy, Sara Napoli, Andrea Rinaldi, Karolina Niewola-Staszkowska, Michael Lahn, Dominique Perrin, Mathias Wenes, Denis Migliorini, Francesco Bertoni #, Lars van der Veen, Giusy

IOA-244 is a Non-ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance

IOA-244 是一种非 ATP 竞争性、高选择性、耐受性良好的 PI3K Delta 抑制剂,可靶向实体瘤并打破免疫耐受。

Zoë Johnson #,Chiara Tarantelli #,Elisa Civanelli,Luciano Cascione,Filippo Spriano,Amy Fraser,Pritom Shah,Tyzoon Nomanbhoy,Sara Napoli,Andrea Rinaldi,Karolina Niewola-Staszkowska,Michael Lahn,Dominique Perrin,Mathias Wenes ,Denis Migliorini ,Francesco Bertoni #,Lars van der Veen,Giusy Di Conza #

Study of the antilymphoma activity of pracinostat reveals different sensitivities of DLBCL cells to HDAC inhibitors

pracinostat 抗淋巴瘤活性研究揭示 DLBCL 细胞对 HDAC 抑制剂的不同敏感性

Afua Adjeiwaa Mensah, Filippo Spriano, Giulio Sartori, Valdemar Priebe, Luciano Cascione, Eugenio Gaudio, Chiara Tarantelli, Elisa Civanelli, Luca Aresu, Andrea Rinaldi, Giovanna Damia, Emanuela Lovati, Emanuele Zucca, Anastasios Stathis, Claudio Pietra, Francesco Bertoni